Skip to main content
SpringerLink
Log in

Renal Osteodystrophy

  • Chapter
Book cover Clinical Decisions in Pediatric Nephrology

  • 1148 Accesses

Abstract

A 19-year old female patient has been treated with hemodialysis for the past 14 years after rejection of a cadaver transplant. Her original disease was Henoch-Schonlein purpura. She now presents with ascending pain and weakness in her hands and feet. There are prominent contractures of her extremities that have caused her to become bedridden over the last four months. Her major problems associated with hemodialysis had been hyperphosphatemia (7 to 8.5 mg/dl) and hypercalcemia (10 to 11 mg/dl) after vitamin D therapy. Her parathyroid hormone (PTH) levels are mildly elevated at 56 pg/ml, although they have been substantially higher in the past. A work-up for collagen vascular disease, including vasculitis, has been negative, as well as Lyme titer and thyroid function tests. Blood glucose has never been elevated. Electromyography and nerve conduction studies are normal. Muscle biopsy shows atrophy and intravascular calcification.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Kunis CL, Markowitz GS, Liu-Jarin X, et al. (2001) Painful myopathy and end-stage renal disease. Am J Kidney Dis 37:1098–1104

    Article  CAS  PubMed  Google Scholar 

  • Bleyer AJ, Burke SK, Dillon M, et al. (1999) A comparison of the calcium-free phosphate binder Sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in dialysis patients. Am J Kidney Dis 33:694–701

    Article  CAS  PubMed  Google Scholar 

  • Mazhar AR, Johnson RJ, Gillen D, et al. (2001) Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60:324–332

    Article  CAS  PubMed  Google Scholar 

  • Malberti F, Marcelli D, Conte F, et al. (2001) Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 12:1242–1248

    CAS  PubMed  Google Scholar 

  • Stehman-Breen CO, Sherrard DJ, Alem AM, et al. (2000) Risks factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:22002205

    Article  Google Scholar 

  • Ferreria MA (2000) Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed. Nephrol Dial Transplant 5:S8–S14

    Article  Google Scholar 

  • Schomig M, Ritz E (2000) Management of disturbed calcium metabolism in uremic patients: 2. Indications for parathyroidectomy. Nephrol Dial Transpl 5:25–9

    Article  Google Scholar 

  • Green J, Debby H, Lederer E, et al. (2001) Evidence for a PTH-independent humeral mechanism in post-transplant hypophosphatemia and phosphaturia. Kidney Int 60: 1182–1196

    Article  CAS  PubMed  Google Scholar 

  • Uribarri J, Calvo MS (2003) Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial 16:186–188

    Article  PubMed  Google Scholar 

  • Colandonato JA, Szczech LA, Friedman EA, et al. (2002) Does calcium kill ESRD patients-the skeptic’s perspective? Nephrol Dial Transplant 17:229–232

    Article  Google Scholar 

  • Jonsson KB, Zahradnik R, Larsson T, et al. (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and x-linked hypophosphatemia. N Engl J Med 348:1656–1563

    Google Scholar 

  • Lindberg JS, Moe SM, Goodman WG, et al. (2003) The calcimimetic AMG 073 reduces parathyroid hormone and calcium × phosphorous in secondary hyperparathyroidism. Kidney Int 63:248–254

    Article  CAS  PubMed  Google Scholar 

  • Tanaka R, Kakuta T, Fujisaki T, et al.. (2003) Long-term (3-years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by color Doppler ultrasonography. Nephrol Dial Transpl 3: (suppl 3) 58–S58–S61

    Google Scholar 

  • Wilmer WA, Magro CM (2002) Calciphylaxis: emerging concept in prevention, diagnosis, and treatment. Semin Dial 15:172–186

    Article  PubMed  Google Scholar 

  • Wang Ay, Wang M, Woo J, et al. (2003) Cardiac valve calcification as an important predictor for all cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 14:159–168

    Article  PubMed  Google Scholar 

  • Goodman WG, Juppner H, Salusky IB, et al. (2003) Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int 63:1–11

    Article  CAS  PubMed  Google Scholar 

  • Horwitz MJ, Tedesco MB, Sereiks SM, et al. (2003) Direct comparison of sustained infusion of human parathyroid hormone-related protein (hPTHrP-(1–36) versus hPTH-(1–34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab 88:1603–1609

    Article  CAS  PubMed  Google Scholar 

  • DeSevaux RG, Hoitsma AJ, Corstens FH, et al. (2002) Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 13: 1608–1614

    Article  CAS  Google Scholar 

  • Silver J, Levi R. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int Suppl. 2005;95:S8–S12

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez M, Nemeth E, Martin D. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 2005; 288:F253–264

    Article  CAS  PubMed  Google Scholar 

  • Fukagawa M, Tominaga Y, Kitaoka M, Kakuta T, Kurokawa K. Medical and surgical aspects of parathyroidectomy. Kidney Int suppl 1999; 73:S65–S69

    Article  CAS  PubMed  Google Scholar 

  • Moe SM, Chertow GM, Coburn JW, et al. (2005) Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCL. Kidney Int. 67:760–771

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez M, Nemeth E, Martin D. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol 2005; 288:F253–264

    Article  CAS  PubMed  Google Scholar 

  • Ritz E (1994) Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? II. Early parathyroidectomy should be considered as the first choice. Nephrol Dial Transplant 9:1819–1821

    CAS  PubMed  Google Scholar 

  • Block GA, Martin KJ, de Francisco AL, et al. (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525

    Article  CAS  PubMed  Google Scholar 

  • Emmett M (2004) A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Kidney Int 90: S25–S32

    Article  CAS  Google Scholar 

  • Martin KJ, Olgaard K, Coburn JW, et al. (2004) Bone Turnover Work Group: Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis 43:558

    Article  PubMed  Google Scholar 

  • Teng M, Wolf M, Lowrie E, et al. (2003) Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349:446–456

    Article  CAS  PubMed  Google Scholar 

  • El-Agroudy AE, El-Husseini AA, El-Sayed M, et al. (2003) Preventing bone loss in renal transplant recipients with vitamin D. J Am Soc Nephrol 14:2975–2979

    Article  CAS  PubMed  Google Scholar 

  • Emmett M (2004) A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Kidney Int Suppl 90:S25–S32

    Article  CAS  PubMed  Google Scholar 

  • Choyke PL, Knopp MV (2003) Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale. Radiology 227:627–628

    Article  PubMed  Google Scholar 

  • Behets GJ, Verberckmoes SC, D’Haese PC, et al. (2004) Lanthanum carbonate:a new phosphate binder. Curr Opin Nephrol Hypertens 13:403–409

    Article  CAS  PubMed  Google Scholar 

  • Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286:E686–696

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rush University Medical Center, Chicago, Illinois

    Farahnak Assadi M.D. (Professor of Pediatrics, Director, Section of Pediatric Nephrology)

Authors
  1. Farahnak Assadi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Assadi, F. (2008). Renal Osteodystrophy. In: Clinical Decisions in Pediatric Nephrology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-74602-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-74602-9_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-74601-2

  • Online ISBN: 978-0-387-74602-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation